Cardiac Metabolism in Health and Disease

Preface.- Glucose and glycogen utilisation in myocardial ischemia - Changes in metabolism and consequences for the myocyte.- Differential regulation in the heart of mitochondrial carnitine palmitoyltransferase-I muscle and liver isoforms.- Carnitine deficiency-induced cardiomyopathy.- Fatty acid-binding proteins in the heart.- Metabolic disturbances in diabetic cardiomyopathy.- Diabetes mellitus and cardiac function.- Phospholipase A2-mediated hydrolysis of cardiac phospholipids: The use of molecular and transgenic techniques.- The role of glucose metabolism in a pig heart model of short-term hibernation.- Glucose metabolism, H+ production and Na+/H+-exchanger mRNA levels in ischemic hearts from diabetic rats.- Regulation of carbohydrate and fatty acid utilization by L-carnitine during cardiac development and hypoxia.- Identification of nucleoside transport binding sites in the human myocardium.- Mutagenesis and characterization of specific residues in fatty acid ethyl ester synthase: A gene for alcohol-induced cardiomyopathy.- Palmitate oxidation by the mitochondria from volume-overloaded rat hearts.- Effects of phosphodiesterase inhibitors on glucose utilization in isolated cardiac myocytes.- Energy metabolism and mechanical recovery after cardioplegia in moderately hypertrophied rats.- Role of nucleoside transport and purine release in a rabbit model of myocardial stunning.- Ischemic preconditioning in rat heart: No correlation between glycogen content and return of function.- The liver isoform of carnitine palmitoyltransferase I is activated in neonatal rat cardiac myocytes by hypoxia.- Human myocardial ATP content and in vivo contractile function.- Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: Role of purinerelease in ischemic and reperfusion injury.- Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.- Index to Volume 180.